Produktbild: Epigenetics and Mirna in Neurodegenerative Diseases
Vorbesteller Neu

Epigenetics and Mirna in Neurodegenerative Diseases From Molecular Mechanisms to Clinical Applications

215,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.02.2027

Herausgeber

Lance R. McMahon + weitere

Verlag

Elsevier

Seitenzahl

325

Maße (L/B)

27,6/21,6 cm

Gewicht

449 g

Sprache

Englisch

ISBN

978-0-443-44845-4

Beschreibung

Portrait

Lance R. McMahon, Ph.D., serves as the Executive Vice President for Research and Innovation at Texas Tech University Health Sciences Center. In his position, Dr. McMahon will serve as chair of the Research Council. Additionally, he has a faculty appointment in the Jerry H. Hodge School of Pharmacy.

Dr. Dharmendra Kumar Khatri is an Associate Professor in the Department of Pharmacology, NIMS Institute of Pharmacy at NIMS University Rajasthan, Jaipur, India.

Dr. Balachandar Vellingiri currently is investigating various neurological diseases and developing human induced pluripotent stem cells (HiPSCs). Exploring the cutting-edge molecular, cellular, and translational neuroscience approaches, he aims to unravel disease mechanisms, identify therapeutic targets, and develop innovative interventions to slow or reverse neurological diseases. His expertise is on several techniques such as molecular cytogenetics, pathway analysis, and techniques in developing HiPSCs and Brain organoids, especially for neurological diseases.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.02.2027

Herausgeber

Verlag

Elsevier

Seitenzahl

325

Maße (L/B)

27,6/21,6 cm

Gewicht

449 g

Sprache

Englisch

ISBN

978-0-443-44845-4

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Epigenetics and Mirna in Neurodegenerative Diseases
  • Section I: Fundamentals of Epigenetics and miRNA in Neurodegeneration
    1. Introduction to Epigenetics and miRNA in neurodegenerative diseases
    2. Epigenetic Mechanisms in the Nervous System
    3. miRNA Biogenesis and Function in Brain Health

    Section II: Epigenetics and miRNA in Specific Neurodegenerative Disorders
    4. Alzheimer’s Disease: Epigenetic and miRNA Contributions
    5. Parkinson’s Disease: The Role of Epigenetic Modifications
    6. Huntington’s Disease: Epigenetic and Post-Transcriptional Control
    7. Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD): Molecular Crosstalk
    8. Multiple Sclerosis: Epigenetic and miRNA Influence on Neuroinflammation

    Section III: Translational and Clinical Applications
    9. Epigenetic Biomarkers in Neurodegenerative Diseases
    10. miRNA-Based Therapeutics: Challenges and Opportunities
    11. Pharmacological and Nutritional Epigenetics in Neuroprotection
    12. Gene Editing and Epigenetic Engineering Approaches
    13. Artificial Intelligence and Computational Epigenomics in Neurodegeneration

    Section IV: Future Perspectives and Ethical Considerations
    14. Personalized Medicine in Neurodegenerative Diseases: The Role of Epigenetics and miRNA
    15. Ethical, Legal, and Social Implications of Epigenetic and miRNA-Based Therapies